2025-18: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. on the Implementation of Foreign Exchange Hedging Activities
2025-19: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. on Utilizing Partially Idle Raised Funds and Proprietary Capital for Cash Management
2025-20: Special Report by Zhejiang Haizheng Biomaterials Co., Ltd. on the Annual Status of Raised Funds' Deposit and Actual Use
2025-21: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. Regarding the Reappointment of the Accounting Firm
2025-22: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. Regarding the Proposal to Authorize the Board of Directors to Handle Matters Related to Small-Scale, Rapid Financing
2025-23: Notice from Zhejiang Haizheng Biomaterials Co., Ltd. Regarding the Convening of the 2024 Annual General Meeting of Shareholders
Summary of Zhejiang Haizheng Biomaterials Co., Ltd.'s 2024 Annual Report
Zhejiang Haizheng Biomaterials Co., Ltd. 2024 Annual Report
2025-24: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. Regarding the Convening of the 2024 Annual and First Quarter 2025 Earnings Conference
Zhejiang Haizheng Biomaterials Co., Ltd. – First Quarter Report for 2025
2025-25: Announcement on the Progress of Share Repurchase by Zhejiang Haizheng Biomaterials Co., Ltd. through Centralized Bidding Transactions
2025-26: Notice Regarding Changes in Shareholder Equity of Zhejiang Haizheng Biomaterials Co., Ltd.
2025-27: Announcement of the 2024 Annual Shareholders’ Meeting Resolution by Zhejiang Haizheng Biomaterials Co., Ltd.
2025-28: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. Regarding the Adjustment of the 2024 Annual Profit Distribution Plan—Dividend Ratio per Share
2025-29: Announcement of Share Reduction Plan by Shareholders of Zhejiang Haizheng Biomaterials Co., Ltd.
2025-30: Announcement on the Implementation of 2024 Annual Equity Distribution by Zhejiang Haizheng Biomaterials Co., Ltd.
2025-31: Announcement by Zhejiang Haizheng Biomaterials Co., Ltd. on the Progress of Share Repurchase
Announcement on Shareholding Changes Exceeding 1% Threshold by a Shareholder Holding Over 5% Equity in Zhejiang Haizheng Biomaterials Co., Ltd. – Results of Share Reduction
2025-33: Announcement on Abnormal Fluctuations in Trading of Shares of Zhejiang Haizheng Biomaterials Co., Ltd.